ClinicalTrials.Veeva

Menu

Sublingual Microcirculation Data of Patients With Systemic Diseases

National Taiwan University logo

National Taiwan University

Status

Unknown

Conditions

Sublingual Microcirculation Status

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT02516215
201505008RINA

Details and patient eligibility

About

This is an observational clinical study, patients with systemic diseases will be enrolled according to the inclusion and exclusion criteria. 360 patients will received the examination of sublingual microcirculation by using sidestream dark filed video microscope. The microcirculation data includes total small vessel density, perfused small vessel density, microvascular flow index, and heterogeneity index. The patients will be divided into right groups according to their systemic diseases as follows: group 1 hypertension (60 patients), group 2 diabetes mellitus (60), group 3 hypertension and diabetes mellitus (60), group 4 end stage renal disease with hemodialysis (60), group 5 peripheral arterial occlusive disease (30), group 6 coronary artery disease (30), group 7 liver cirrhosis (30), and group 8 anemia (30).

Enrollment

360 estimated patients

Sex

All

Ages

20 to 79 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged from 20 to 79 years old

  • BMI ranged from 18.5 to 27 kg/m2

  • Presence of one of the condition

    1. Diagnosed hypertenison > 6 months, without other systemic diseases
    2. Diagnosed diabetes mellitus > 6 monthes, without other systemic diseases
    3. Diagnosed with both hypertension and diabetes mellitus > 6 months, without other systemic diseases
    4. Diagnosed with end stage renal disease and recevied renal replacement therapy > 6 months
    5. Diagnosed with peripheral arterial occlusive diseases > 6 months
    6. Diagnosed with coronary artery disease > 6 months
    7. Diagnosed with liver cirrhosis > 6 months
    8. Diagnosed with anemia > 6 months, hemoglobin level < 10 g/dL

Exclusion criteria

  • Diagnosed with sepsis, major tauma, or admission to ICU within one month

  • Body temperature higher than 37.5 ℃ or lower than 35.5 ℃

  • Any on of the following condition

    1. Asthma
    2. Chronic obstructive pulmonary disease
    3. Endocrine diseases
    4. Hematological disorders
    5. Uncured cancer
    6. Chronic uncured infection
    7. Other major disease with limited daily activity
  • Non-native speakers

Trial design

360 participants in 8 patient groups

1_Hypertension
Description:
Patients with diagnosed hypertension, without other systemic diseases
Treatment:
Other: No intervention
2_Diabetes mellitus
Description:
Patients with diagnosed diabetes mellitus, without other systemic diseases
Treatment:
Other: No intervention
3_Hypertension and diabetes mellitus
Description:
Patients with both diagnosed hypertension and diabetes mellitus
Treatment:
Other: No intervention
4_end stage renal disease with hemodialysis
Description:
Patients with end stage renal disease with hemodialysis
Treatment:
Other: No intervention
5_Peripheral arterial occlusive disease
Description:
Patients with disgnosed peripheral arterial occlusive disease
Treatment:
Other: No intervention
6_Coronary artery disease
Description:
Patients with diagnosed coronary artery disease
Treatment:
Other: No intervention
7_liver cirrhosis
Description:
Patients with diagnosed liver cirrhosis
Treatment:
Other: No intervention
8_Anemia
Description:
Patients with diagnosed anemia
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Central trial contact

Yu-Chang Yeh, M.D., Ph.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems